Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

29.07.2025    NPR News    3 views
Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine The company says it trying to stop them Image credit Scott Olson

Similar News

Could Donald Trump's Push for Republicans To Redis
Could Donald Trump's Push for Republicans To Redistrict Backfire?

Republicans view mid-decade redraws as a tool to thwart Democratic midterm gains. Experts weighed in...

30.07.2025 1
Read More
NYPD commissioner steps up with ‘sea of blue’ after cop, 3 others killed in office attack
NYPD commissioner steps up with ‘sea of blue’ after cop, 3 others killed in office attack

Hours after a gunman opened fire inside a New York City high-rise office building on Monday, the new...

30.07.2025 1
Read More
China Buys Up Property in America's Hottest Housin
China Buys Up Property in America's Hottest Housing Market

This city in the chilly Northeast, where a Chinese company sparked controversy by buying land, is th...

30.07.2025 1
Read More